Sectoral Asset Management Inc Apellis Pharmaceuticals, Inc. Transaction History

Sectoral Asset Management Inc

$203 Million
Q1 2024

A detailed history of Sectoral Asset Management Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 9,670 shares of APLS stock, worth $370,941. This represents 0.28% of its overall portfolio holdings.

Number of Shares

9,670

Previous 5,220 85.25%

Holding current value

$370,941

Previous $312,000 82.05%

% of portfolio

0.28%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$55.39 - $72.47 $246,485 - $322,491	4,450 Added 85.25%	9,670 $568,000
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $3.28 Million - $12.4 Million	-138,639 Reduced 96.37%	5,220 $198,000
Q2 2023 Aug 11, 2023	SELL	$76.68 - $93.31 $2.2 Million - $2.67 Million	-28,631 Reduced 16.6%	143,859 $13.1 Million
Q1 2023 May 12, 2023	BUY	$46.59 - $66.96 $938,788 - $1.35 Million	20,150 Added 13.23%	172,490 $11.4 Million
Q4 2022 Feb 10, 2023	BUY	$43.24 - $61.04 $1.23 Million - $1.73 Million	28,350 Added 22.86%	152,340 $7.88 Million

Q3 2022 Nov 10, 2022	SELL	$44.76 - $69.66 $1.31 Million - $2.04 Million	-29,260 Reduced 19.09%	123,990 $8.47 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $2.94 Million - $4.96 Million	83,750 Added 120.5%	153,250 $6.93 Million
Q1 2022 May 10, 2022	BUY	$35.46 - $54.12 $2.46 Million - $3.76 Million	69,500 New	69,500 $3.53 Million
Q1 2021 May 14, 2021	SELL	$40.8 - $57.39 $2.65 Million - $3.73 Million	-65,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$30.79 - $57.2 $2 Million - $3.72 Million	65,000 New	65,000 $3.72 Million
Q3 2020 Nov 13, 2020	SELL	$25.89 - $33.65 $19.9 Million - $25.9 Million	-768,609 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$24.8 - $38.49 $9.66 Million - $15 Million	389,686 Added 102.84%	768,609 $25.1 Million
Q1 2020 May 13, 2020	SELL	$17.91 - $44.33 $1.37 Million - $3.39 Million	-76,470 Reduced 16.79%	378,923 $10.2 Million
Q4 2019 Feb 12, 2020	SELL	$22.1 - $30.8 $12 Million - $16.7 Million	-541,590 Reduced 54.32%	455,393 $13.9 Million
Q3 2019 Nov 14, 2019	SELL	$24.09 - $32.18 $11.9 Million - $15.9 Million	-492,974 Reduced 33.09%	996,983 $24 Million
Q2 2019 Aug 14, 2019	SELL	$18.0 - $25.34 $4.28 Million - $6.03 Million	-237,872 Reduced 13.77%	1,489,957 $37.8 Million
Q1 2019 May 14, 2019	SELL	$12.81 - $19.82 $5.64 Million - $8.73 Million	-440,286 Reduced 20.31%	1,727,829 $33.7 Million
Q4 2018 Feb 12, 2019	BUY	$11.47 - $18.71 $1.49 Million - $2.42 Million	129,599 Added 6.36%	2,168,115 $28.6 Million
Q3 2018 Nov 14, 2018	BUY	$16.57 - $21.03 $4.9 Million - $6.22 Million	295,894 Added 16.98%	2,038,516 $36.2 Million
Q2 2018 Aug 13, 2018	BUY	$19.63 - $30.0 $1.86 Million - $2.85 Million	94,930 Added 5.76%	1,742,622 $38.3 Million
Q1 2018 May 15, 2018	SELL	$14.01 - $26.02 $1.47 Million - $2.73 Million	-104,963 Reduced 5.99%	1,647,692 $36.4 Million
Q4 2017 Feb 13, 2018	BUY	$12.71 - $21.7 $22.3 Million - $38 Million	1,752,655	1,752,655 $38 Million

Others Institutions Holding APLS

# of Institutions

337

Shares Held

111M

Call Options Held

1.26M

Put Options Held

1.14M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $4.21B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Apellis Pharmaceuticals, Inc. Transaction History